Microvascular disease and renal disease progression

Journal of the Medical Association of Thailand

Volumn 87, Issue 7, 2004, Pages 854-859

  Futrakul, Narisa ^a   Futrakul, Prasit ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CAPILLARY FLOW; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS CAPILLARY; HEMODYNAMICS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TUBULE ABSORPTION; MAGNESIUM EXCRETION; MICROANGIOPATHY; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PODOCYTE; REVIEW; ULTRAFILTRATION; URINALYSIS; VASOCONSTRICTION;

DISEASE PROGRESSION; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; REGIONAL BLOOD FLOW;

EID: 4444306457     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis 2003; 41: 1-13.
2. Tungsanga K, Sumethakul V. Suggestions for screening and treating chronic kidney disease. Thai Med Council Bull 2004; 33: 30-6.
3. Futrakul N, Vongthavarawat V, Chairatanarat T, Sirisalipotch S, Futrakul P, Suwanwalaikorn. Altered renal functions in normoalbuminuric diabetes type 2 Intern Med J Thai (in press).
4. Risdon RA, Sloper K, De Wardener HE. Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968; 1: 363-6.
5. Schainuch LI, Striker GE, Cutter RE, Benditt EP. Structural-functional correlations in renal disease. Part II: The correlations. Hum Pathol 1970; 1: 631-40.
6. Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular function and tubulo interstitial disease. Am J Kidney Dis 1999; 33: 886-91.
7. Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A. Watanapenpaibul K, et al. Peritubular capillary flow determines tubulo interstitial disease in nephrotic syndrome. Ren Fail 2000; 22: 329-35.
8. Futrakul P, Sitprija V, Yenrudi S, Poshyachinda M, Sensirivatana R, Watana D, et al. Glomerular endothelial dysfunction determines disease progression: A hypothesis. Am J Nephrol 1997; 17: 533-40.
9. Futrakul P, Poshyachinda M, Yenrudi S, Salikul P, Sensirivatana R, Futrakul N, et al. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: Therapeutic benefit with vasodilator. J Med Assoc Thai 1992; 75: 375-85.
10. Futrakul N, Siriviriyakul P, Deekajorndej T, Futrakul P. Hemodynamic maladjustment and disease progression in nephrosis with FSGS. Ren Fail (in press).
11. Futrakul N, Panichakul T, Sirisinha S, Futrakul P, Siriviriyakul P. Glomerular endothelial dysfunction in chronic kidney disease. Ren Fail (in press).
12. Futrakul N, Laohaphaibul A, Futrakul P. Glomerular endothelial dysfunction and hemodynamic malad justment in vesicoureteric reflux. Ren Fail 2003; 25: 479-83.
13. Futrakul P, Siriviriyakul P, Paumraj S, Bunnag S, Kulputana O, Futrakul N. A hemodynamically mediated mechanism of renal disease progression in severe glomerulonephritides or nephrosis. Clin Hemorheol Microcirc 2003; 29: 183-7.
14. Futrakul N, Boonyen M, Patumraj S, Siriviriyakul P, Tosukhowong P, Futrakul P. Treatment of glomerular endothelial dysfunction in seteroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators. Clin Hemorrheol Microcirc 2003; 29: 205-10.
15. Kriz W, Elger M, Nagata M, Kretzlar M, Uiker S, Koeppen-Hagemann E, et al. The role of podocytes in the development of glomerulosclerosis. Kidney Int 1994; 45(suppl 45): 64-75.
16. Rennke HG. How does glomerular epithelial injury contribute to progressive glomerular damage? Kidney Int 1994; 45(suppl 45): 58-63.
17. Fan L, Wakayama T, Yokoyama S, Wakayarna T, Yokoyarna S, Amano O, Iseki SF. Down-regulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. Nephron 2002; 90: 95-102.
18. Ruiz-Ortega M, Egido J. Angiotensin 11 modulates cell growth-related events and thesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997; 52: 1497-510.
19. Bottinger EP, Bitzer M. TGF-B signaling in renal disease. J Am Soc Nephrol 2002; 13: 260-9.
20. Kang DH, Anderson S, Kim YG, Mazzali M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Herghes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiotenesis in the aging kidney: Potensital role of VEGF and TSP-1 in renal disease. Am J Kidney Dis 2001; 37: 601-11.
21. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Tauong LD. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31: 1491-2.
22. Ostendorf T, Kunter U, Loos A, Eitner F, Regele H, Kerjaschki D, Janji N, Floege J. Vascular endothelial growth factor (VEGF165) mediates glomerular endothelial repair. J Clin Invest 1999; 104: 913-23.
23. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of post-glomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191-5.
24. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-16.
25. Yenrudi S, Laohapaibul A, Kittidiwit W, Suteparuk S, Futrakul N. A correlation between renal morphology and renal circulation in pediatric nephritic syndrome. Ren Fail 2001; 23: 85-90.
26. Futrakul N, Kittikowit W, Yenrudi S. Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis. Ren Fail 2003; 25: 759-64.
27. Fine LG, Ong ACM, Norman JT. Mechanism of tubulo interstitial injury in progressive renal disease. Eur J Clin Invest 1993; 23: 259-65.
28. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, Johnson RJ. Microvascular and tubulo interstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 2003; 63: 2088-93.
29. Manotham K, Tanaka T, Matsumoto M, Ohsc T, Inagi R, Miyato T, et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-80.
30. Futrakul N, Futrakul P, Siriviriyakul P. Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis. Clin Hemorheol Microcirc (in press).
31. Futrakul N, Tosukhowong P, Valyapongpichit Y, Tipprukmas N, Futrakul P, Patumraj S. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication. Ren Fail 2002; 24: 433-45.
32. Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, et al. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 2003; 63: 1094-110.
33. Morgensen CE, Neldam S, Tikkanen I, Oen S, Viskoper R, Watts RW, Cooper ME. Randomized controlled trial of dual blockade of rennin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000; 321: 1440-4.
34. Gisen A. Randomized placebo-controlled trial effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuria, non-diabetic nephropathy. Lancet 1997; 349: 1857-63.
35. Ruggenenti P, Perna A, Benini R, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR. J Am Soc Nephrol 1999; 10: 997-1006.